Insulin Glargine Pharmacology

Insulin glargine serves as a long-acting basal insulin providing consistent blood glucose coverage throughout the day for patients with type 1 and type 2 diabetes. Unlike rapid-acting insulins, glargine has an onset of approximately three to four hours and a 24-hour duration, making it unsuitable for managing acute post-meal spikes. Effective clinical management requires cautious dose titration—typically in 10 to 20 percent increments every three to seven days—to minimize the risk of hypoglycemia and weight gain. Practitioners must exercise vigilance during medication transitions, as confusion between pen devices or insulin types often leads to dosing errors. While insulin generally lacks significant drug interactions, clinicians should monitor for potential hypoglycemia when combining glargine with other diabetes agents or when patients use medications like corticosteroids that may counteract insulin’s glucose-lowering effects.